Shalby Limited (SHALBY) - Net Assets
Based on the latest financial reports, Shalby Limited (SHALBY) has net assets worth Rs10.06 Billion INR (≈ $108.76 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs18.39 Billion ≈ $198.89 Million USD) and total liabilities (Rs8.33 Billion ≈ $90.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset allocation strategy of Shalby Limited to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs10.06 Billion |
| % of Total Assets | 54.68% |
| Annual Growth Rate | 18.88% |
| 5-Year Change | 14.78% |
| 10-Year Change | 265.08% |
| Growth Volatility | 43.8 |
Shalby Limited - Net Assets Trend (2012–2026)
This chart illustrates how Shalby Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see SHALBY market cap.
Annual Net Assets for Shalby Limited (2012–2026)
The table below shows the annual net assets of Shalby Limited from 2012 to 2026. Also explore how fast is Shalby Limited growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs10.06 Billion ≈ $108.76 Million |
+1.04% |
| 2025-03-31 | Rs9.95 Billion ≈ $107.64 Million |
-1.24% |
| 2024-03-31 | Rs10.08 Billion ≈ $108.99 Million |
+8.64% |
| 2023-03-31 | Rs9.28 Billion ≈ $100.32 Million |
+5.87% |
| 2022-03-31 | Rs8.76 Billion ≈ $94.76 Million |
+4.97% |
| 2021-03-31 | Rs8.35 Billion ≈ $90.27 Million |
+4.44% |
| 2020-03-31 | Rs7.99 Billion ≈ $86.43 Million |
+2.49% |
| 2019-03-31 | Rs7.80 Billion ≈ $84.34 Million |
+2.41% |
| 2018-03-31 | Rs7.62 Billion ≈ $82.35 Million |
+176.43% |
| 2017-03-31 | Rs2.75 Billion ≈ $29.79 Million |
+24.27% |
| 2016-03-31 | Rs2.22 Billion ≈ $23.97 Million |
+29.81% |
| 2015-03-31 | Rs1.71 Billion ≈ $18.47 Million |
+19.08% |
| 2014-03-31 | Rs1.43 Billion ≈ $15.51 Million |
+35.63% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.43 Million |
+18.40% |
| 2012-03-31 | Rs892.99 Million ≈ $9.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shalby Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs1.08 Billion | 10.70% |
| Other Components | Rs8.98 Billion | 89.30% |
| Total Equity | Rs10.05 Billion | 100.00% |
Shalby Limited Competitors by Market Cap
The table below lists competitors of Shalby Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Adairs Ltd
AU:ADH
|
$159.24 Million |
|
Wei Chih Steel Industrial Co Ltd
TW:2028
|
$159.25 Million |
|
Novonix Ltd ADR
NASDAQ:NVX
|
$159.30 Million |
|
GalaxyEdge Acquisition Corporation
NYSE:GLED
|
$159.35 Million |
|
Han Kook Capital Co. Ltd
KQ:023760
|
$159.21 Million |
|
HUYA Inc
F:HY5A
|
$159.21 Million |
|
Leatec Fine Ceramics Co Ltd
TWO:6127
|
$159.19 Million |
|
LaFayette Acquisition Corp. Ordinary Share
NASDAQ:LAFA
|
$159.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shalby Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 9,921,880,000 to 10,052,340,000, a change of 130,460,000 (1.3%).
- Net income of 373,890,000 contributed positively to equity growth.
- New share issuances of 320,000 increased equity.
- Other comprehensive income decreased equity by 20,069,999.
- Other factors decreased equity by 223,680,001.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs373.89 Million | +3.72% |
| Share Issuances | Rs320.00K | +0.0% |
| Other Comprehensive Income | Rs-20.07 Million | -0.2% |
| Other Changes | Rs-223.68 Million | -2.23% |
| Total Change | Rs- | 1.31% |
Book Value vs Market Value Analysis
This analysis compares Shalby Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 17.60x to 1.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-03-31 | Rs7.80 | Rs137.21 | x |
| 2013-03-31 | Rs9.44 | Rs137.21 | x |
| 2014-03-31 | Rs13.04 | Rs137.21 | x |
| 2015-03-31 | Rs15.59 | Rs137.21 | x |
| 2016-03-31 | Rs20.49 | Rs137.21 | x |
| 2017-03-31 | Rs25.50 | Rs137.21 | x |
| 2018-03-31 | Rs80.70 | Rs137.21 | x |
| 2019-03-31 | Rs72.20 | Rs137.21 | x |
| 2020-03-31 | Rs73.99 | Rs137.21 | x |
| 2021-03-31 | Rs77.28 | Rs137.21 | x |
| 2022-03-31 | Rs81.13 | Rs137.21 | x |
| 2023-03-31 | Rs86.36 | Rs137.21 | x |
| 2024-03-31 | Rs92.45 | Rs137.21 | x |
| 2025-03-31 | Rs92.50 | Rs137.21 | x |
| 2026-03-31 | Rs86.84 | Rs137.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shalby Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.28%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.83x
- Recent ROE (3.72%) is below the historical average (11.60%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 30.10% | 14.25% | 1.70x | 1.24x | Rs169.24 Million |
| 2013 | 16.78% | 7.60% | 1.48x | 1.49x | Rs69.11 Million |
| 2014 | 27.70% | 15.08% | 1.19x | 1.54x | Rs249.40 Million |
| 2015 | 15.28% | 9.34% | 0.78x | 2.09x | Rs88.90 Million |
| 2016 | 16.98% | 12.94% | 0.56x | 2.35x | Rs154.53 Million |
| 2017 | 22.72% | 19.23% | 0.45x | 2.61x | Rs350.21 Million |
| 2018 | 5.64% | 11.20% | 0.40x | 1.27x | Rs-332.21 Million |
| 2019 | 4.06% | 6.87% | 0.49x | 1.20x | Rs-463.18 Million |
| 2020 | 3.45% | 5.67% | 0.50x | 1.21x | Rs-523.30 Million |
| 2021 | 5.08% | 9.84% | 0.43x | 1.19x | Rs-410.69 Million |
| 2022 | 6.18% | 7.74% | 0.59x | 1.36x | Rs-335.07 Million |
| 2023 | 7.30% | 8.41% | 0.63x | 1.38x | Rs-250.68 Million |
| 2024 | 8.40% | 9.00% | 0.58x | 1.61x | Rs-159.60 Million |
| 2025 | 0.63% | 0.57% | 0.64x | 1.72x | Rs-929.97 Million |
| 2026 | 3.72% | 3.28% | 0.62x | 1.83x | Rs-631.34 Million |
Industry Comparison
This section compares Shalby Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $7,128,161,154
- Average return on equity (ROE) among peers: 6.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shalby Limited (SHALBY) | Rs10.06 Billion | 30.10% | 0.83x | $159.22 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $16.78 Billion | 7.97% | 0.95x | $13.55 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $13.71 Billion | 12.97% | 1.11x | $4.14 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $141.49 Million |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $1.10 Billion |
| Jupiter Life Line Hospitals Limited (JLHL) | $3.64 Billion | 20.03% | 1.71x | $976.92 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $-1.38 Billion | 0.00% | 0.00x | $3.32 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $526.97 Million | 2.98% | 0.12x | $24.87 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $10.34 Billion | -2.01% | 2.21x | $10.84 Billion |
| Max India Limited (MAXIND) | $6.37 Billion | -2.53% | 0.34x | $84.74 Million |
| Global Health Limited (MEDANTA) | $16.16 Billion | 12.14% | 0.95x | $4.12 Billion |
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology servic… Read more